Published in Virology on December 20, 1995
Applications of flow cytometry to clinical microbiology. Clin Microbiol Rev (2000) 1.69
Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J Virol Methods (2005) 1.62
Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics. Rev Med Virol (2013) 1.54
Induction of apoptosis by La Crosse virus infection and role of neuronal differentiation and human bcl-2 expression in its prevention. J Virol (1996) 1.50
Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide. Virology (2006) 1.06
Severe acute respiratory syndrome coronavirus gene 7 products contribute to virus-induced apoptosis. J Virol (2007) 1.02
Functional analysis of the Bunyamwera orthobunyavirus Gc glycoprotein. J Gen Virol (2009) 0.97
La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic. Virology (2010) 0.85
Prevalence and protein specificity of human antibodies to Inkoo virus infection. Clin Vaccine Immunol (2007) 0.85
Expression and characterization of a soluble form of tomato spotted wilt virus glycoprotein GN. J Virol (2004) 0.83
Thrips and tospoviruses come of age: mapping determinants of insect transmission. Proc Natl Acad Sci U S A (2005) 0.77
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol (1992) 4.85
Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature (1972) 4.08
CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol (1989) 2.77
Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science (1991) 2.77
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68
Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc Natl Acad Sci U S A (1989) 2.66
Seasonality and the requirements for perpetuation and eradication of viruses in populations. Am J Epidemiol (1979) 2.58
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology (1992) 2.41
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37
Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide. Nature (1968) 2.16
The genetics of susceptibility to multiple sclerosis. Epidemiol Rev (1982) 2.00
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A (1993) 1.96
Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. Lab Invest (1976) 1.96
The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am J Epidemiol (1979) 1.87
Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 1.80
Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res (1970) 1.79
Human exposure to SV40: review and comment. Am J Epidemiol (1976) 1.77
Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Fed Proc (1972) 1.66
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Fatal Japanese encephalitis virus infection in immunosuppresed spider monkeys. Clin Exp Immunol (1970) 1.61
The effect of soft cervical collars on persistent neck pain in patients with whiplash injury. Acad Emerg Med (1996) 1.61
Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol (1982) 1.60
Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J Infect Dis (1974) 1.51
Induction of apoptosis by La Crosse virus infection and role of neuronal differentiation and human bcl-2 expression in its prevention. J Virol (1996) 1.50
Lymphocytic choriomeningitis. Pathogenesis. Prog Med Virol (1974) 1.47
Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response. J Infect Dis (1978) 1.46
Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab Invest (1984) 1.44
Experimental infection of monkeys with Langat virus II. Turnover of circulating virus, 1967. Rev Med Virol (2000) 1.42
Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest (1976) 1.42
Eradication of poliomyelitis in the United States. Rev Infect Dis (1983) 1.42
Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. J Virol (1993) 1.37
Experimental encephalitis following peripheral inoculation of West Nile virus in mice of different ages. J Hyg (Lond) (1970) 1.34
Pathogenesis of West Nile Virus encepahlitis in mice and rats. II. Virus multiplication, evolution of immunofluorescence, and development of histological lesions in the brain. Am J Epidemiol (1967) 1.31
An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol (1984) 1.30
Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology (1986) 1.29
Pathogenesis of West Nile Virus encephalitis in mice and rats. 1. Influence of age and species on mortality and infection. Am J Epidemiol (1967) 1.28
Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA. Virology (1993) 1.27
Organization of the middle RNA segment of snowshoe hare Bunyavirus. Virology (1988) 1.26
Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis (1994) 1.24
Histological studies of the monkey neurovirulence of group B arboviruses. I. A semiquantitative grading scale. Am J Epidemiol (1965) 1.24
Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. Virology (1982) 1.23
Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. 1. Evolution of disease following infection at 4 days of age. J Neuropathol Exp Neurol (1973) 1.21
The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells. J Immunol (1978) 1.19
Bovine spongiform encephalopathy (BSE): causes and consequences of a common source epidemic. Am J Epidemiol (1997) 1.19
Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology (1988) 1.18
Acute rabies death mediated by antibody. Nature (1981) 1.17
Completion of the La Crosse virus genome sequence and genetic comparisons of the L proteins of the Bunyaviridae. Virology (1995) 1.16
Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Virology (1993) 1.13
Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies. J Virol (1995) 1.13
An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function. J Virol (1985) 1.12
Estimating the temporal and spatial risk of bluetongue related to the incursion of infected vectors into Switzerland. BMC Vet Res (2008) 1.11
Heterotopic cerebellar granule cells following administration of cyclophosphamide to suckling rats. Brain Res (1969) 1.11
Humoral and bronchial immune responses in cattle experimentally infected with Mycoplasma mycoides subsp. mycoides small colony type. Vet Microbiol (1998) 1.11
Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. Virology (1994) 1.09
Immunosuppression: a means to assess the role of the immune response in acute virus infections. Fed Proc (1972) 1.09
Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses. Annu Rev Microbiol (1993) 1.08
Development of a sensitive nested PCR method for the specific detection of Mycoplasma mycoides subsp. mycoides SC. Mol Cell Probes (1997) 1.08
[Bluetongue disease reaches Switzerland]. Schweiz Arch Tierheilkd (2008) 1.07
Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. J Gen Virol (1983) 1.07
Experimental visna in Icelandic sheep: the prototype lentiviral infection. Rev Infect Dis (1985) 1.06
Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment. J Virol (1991) 1.03
Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. J Biol Chem (1994) 1.03
Detection of IgM antibodies against canine distemper virus in dog and mink sera employing enzyme-linked immunosorbent assay (ELISA). J Vet Diagn Invest (1991) 1.03
Oligodendroglial pathology in canine distemper virus infection in vitro. Acta Neuropathol (1987) 1.03
Virulence of La Crosse virus is under polygenic control. J Virol (1986) 1.02
A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus. Science (1987) 1.02
Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers. Am J Epidemiol (1966) 1.02
The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the Spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. 1963. Am J Epidemiol (1995) 1.02
The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein. J Gen Virol (1989) 1.01
Effect of antilymphocyte serium on tacaribe virus infection in infant mice. Infect Immun (1971) 1.01
Epidemiology of multiple sclerosis: critique of the evidence for a viral etiology. Am J Epidemiol (1978) 1.00
La Crosse virus G1 glycoprotein undergoes a conformational change at the pH of fusion. Virology (1985) 1.00
Characterization of the gene for an immunodominant 72 kDa lipoprotein of Mycoplasma mycoides subsp. mycoides small colony type. Microbiology (1996) 1.00
Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol (1995) 0.98
Histological studies of the monkey neurovirulence of group B arboviruses. IV. Evaluation of an attenuated strain (E5) of Langat virus. Am J Epidemiol (1968) 0.98
Polygenic control of neuroinvasiveness in California serogroup bunyaviruses. J Virol (1993) 0.98
Human choroid plexus cells can be latently infected with human immunodeficiency virus. Ann Neurol (1989) 0.97
Viral hemorrhagic encephalopathy of rats. II. Pathogenesis of central nervous system lesions. Am J Epidemiol (1970) 0.96
Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging. Ann Neurol (1987) 0.96